Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) [Phase 3]

View source ↗

Summary

TreatResp is an adaptive platform Phase 3 trial evaluating treatments for influenza A, influenza B, COVID-19, and other acute respiratory infections in communit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Unity Health Toronto | Conditions: Influenza A, Influenza B | Phase 3 | Status: NOT_YET_RECRUITING